We are excited to announce the start of patient enrollment for the IXION 2.0 clinical trial at the Goethe University Hospital Frankfurt. Due to the evolving dynamics of COVID-19, the project’s focus has shifted to investigating the potential benefits of the FX06 drug for patients with acute respiratory distress syndrome (ARDS). Spearheaded by Prof. Zacharowski and Dr. Petra Wülfroth, the co-founder of F4 Pharma in Vienna, the consortium and clinical trial were restructured in record time, underlining the unwavering joint commitment to innovative medical research in critical health conditions.

Our COVend consortium member F4 Pharma’s cooperation partners presented groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome (ISCLS), also known as Clarkson disease, first at the 124° Congresso Nazionale of the Societa Italiana di Medicina Interna (SIMI) in October 2023. Now their paper is officially published in Biomedicine & Pharmacotherapy.

On the 13th of November, the consortium member of our partner institution UMCG, Clazinus Veijer, presented his poster “Lessons learned from model-based economic evaluations of COVID-19 treatments under pandemic circumstances: results from a systematic review ” at ISPOR Europe 2023. The poster highlighted results from a systematic review of various methodological characteristics of model-based economic evaluations of COVID-19 treatments.

Exciting research from COVend presented at the joint conference of the Société Française d’Immunologie & Deutsche Gesellschaft für Immunologie in Strasbourg!

COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19 In the ongoing fight against COVID-19, COVend is dedicated to pushing the boundaries of scientific knowledge. Together with

In 2015, the United Nations adopted the 17 Sustainable Development Goals (SDGs) as a global blueprint for addressing pressing challenges. These goals guide our efforts to combat poverty, inequality, climate change, and environmental concerns. Among them, two pivotal goals stand out – SDG 3: Good Health and Well-being, and SDG 9: Industry, Innovation and Infrastructure.

What do an economist, a biochemist, and a clinician have in common? As it turns out, they can all benefit from the latest findings on FX06. The researchers from University College Dublin and the University Medical Center Groningen, the esteemed COVend consortium partners, have revealed new information on FX06 and its potential role in addressing hyperinflammation and capillary leak.

COVend publication: “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” We are thrilled to announce the publication of “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” by our esteemed partners Jan Kloka,

Highway to Health – the future of Healthcare in Europe COVend & ENVISION Cluster and Policy Event On 4 July 2023 the two project consortia of COVend and ENVISION, held

COVend represented at Euroanaesthesia Congress 2023 The COVend partners European Society of Anaesthesiology and Intensive Care (ESAIC), held a successful Euroanaesthesia 2023 (EA23) Congress from 03 June 2023 – 05

HIGHWAY TO HEALTH – EVENT REGISTRATION OPEN Register for our joint COVend & ENVISION Cluster and Policy Event “Highway to Health — Visions in European Healthcare” at the Representation of the State

5th Steering Committee Meeting of COVend Last week, on the 24th of April, 40 consortium members of 11 project partners gathered for one day to hold the fifth Steering Committee

HIGHWAY TO HEALTH – COVend at the ENVISION project final event On the 24th of January, COVend joined the ENVISION project fianl event, Highway to Health in Brussels. As the

COVend, COVIRNA, ENVISION joint webinar “Addressing unmet clinical needs, practices and patient outcomes: the impact of EU-funded projects” On the 5th of January, COVend together with two other EU-funded projects

4th Steering Committee Meeting of COVend On the 10th and 11th of October, the COVend consortium came together in Barcelona to discuss the state of play of the project and

We are happy to announce that after just about a year from the project start, the study protocol of IXION has now been published! Background More than 2.7 million hospitalizations

Prof. Zacharowski receives the Honorary Award of the European Society for Anesthesiology and Intensive Care Prof. Dr. Dr. Kai Zacharowski, Director of the Department of Anesthesiology, Intensive Care and Pain

COVend represented in Euroanaesthesia 2022 Euroanaesthesia is recognised worldwide as one of the most important and influential annual congresses in anaesthesiology and intensive care. During this year’s edition, COVend was

3rd Steering Committee meeting of COVend The COVend Steering Committee was held on the 17th of May in beautiful Brussels, Belgium, following a hybrid format. This event was an opportunity

The COVend research project aims to deliver a new therapy against COVID-19 that prevents the severe stages of the disease Since the beginning of the coronavirus pandemic, over 2.7 million hospitalisations

Coordinator of the COVend project, Prof. Dr. Dr. Kai Zacharowski, MD PhD ML FRCA is the Director of the Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy at the

On the 31st August all partners of COVend had a successful online meeting marking the official Kick-Off of this new Horizon 2020 project which will run until August 2024. All 17

In the emergency call HORIZON-HLTH-2021-CORONA-01-01, COVend was one of the six funded projects, from a total of 36 submissions. 17 partners from 13 different countries make up COVend consortium. The other projects funded